Skip to main content

Table 6 Estimations of Morquio A point prevalence from birth prevalence data

From: A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases

 

Birth prevalence (per 10, 000)*

Estimated MPS IVA point prevalence #

Estimated MPS IVA point prevalence per 10,000

Estimated people alive with MPSIVA

Australia KOL [27]

0.04

1 per 810,000

0.0123

27

Germany [32]

0.038

1 per 835,000

0.0120

97

UAE (Emirates) [25]

0.14

1 per 217,000

0.0460

25

Australia [31]

0.0497

1 per 652,000

0.0153

34

Canada (BC) [30]

0.048

1 per 668,000

0.0150

7

Japan (POR) [35]

0.02

1 per 1,664,000

0.0060

76

  1. Abbreviations: BC British Columbia, KOL Key Opinion Leader, POR Patient organisation representative, NI Northern Ireland, UAE United Arab Emirates, UK United Kingdom, W West. *Calculated by authors from Tables 4 and 5; #average point prevalence for study period.
  2. Estimated MPS IVA patients alive = MPSIVA point prevalence × population.